Showing results (301-310 of 517) with videos related to
Sort By:
Pageof 52
JACC. Case Reports|October 27, 2022
Implementation of Novel Lipid Therapies in a Refractory Heterozygous Familial Hypercholesterolemia Patient With Atherosclerotic DiseaseSpencer F Weintraub, Jessica A Schillow, Bani M Azari, et al.Archives of Internal Medicine|February 15, 2001
Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparinS M Bates, J I Weitz, M Johnston, et al.Molecular Pharmacology|December 23, 2000
The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholaminesP Pörzgen, S K Park, J Hirsh, et al.Thrombosis Research|December 15, 1988
Heparin clearance and ex vivo recovery in newborn piglets and adult pigsM Andrew, F Ofosu, B Schmidt, et al.The Journal of Clinical Investigation|November 1, 1981
Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit plateletsM A Blajchman, A F Senyi, J Hirsh, et al.British Journal of Haematology|October 1, 1986
The haemorrhagic and antithrombotic effects of dermatan sulphateF Fernandez, J Van Ryn, F A Ofosu, et al.Thrombosis and Haemostasis|October 31, 1988
Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosisB Schmidt, M R Buchanan, F Ofosu, et al.Journal of Clinical Lipidology|February 18, 2026
How is obesity defined? Moving beyond the limitations of current measures to redefine obesityAdam Chang, Andrew Cyr, Spencer Weintraub, et al.Journal of the American College of Cardiology|December 16, 2014
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular diseaseRobert S Rosenson, Michael H Davidson, Benjamin J Hirsh, et al.Annals of Internal Medicine|January 15, 1997
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapyL Harrison, M Johnston, M P Massicotte, et al.Pageof 52